Cargando…
Exon 2: Is it the good police in familial mediterranean fever?
OBJECTIVE: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease. Most of the identified disease-causing mutations are located on exon 10. As the number of studies about the effect of the exonal location of the mutation and its phenotypic expression is limited, we aimed to i...
Autores principales: | Bilge, Şule Yaşar, Solmaz, Dilek, Şenel, Soner, Emmungil, Hakan, Kılıç, Levent, Öner, Sibel Yılmaz, Yıldız, Fatih, Yılmaz, Sedat, Bozkırlı, Duygu Ersözlü, Tufan, Müge Aydın, Yılmaz, Sema, Yazısız, Veli, Pehlivan, Yavuz, Beş, Cemal, Çetin, Gözde Yıldırım, Erten, Şükran, Gönüllü, Emel, Şahin, Fezan, Akar, Servet, Aksu, Kenan, Kalyoncu, Umut, Direskeneli, Haner, Erken, Eren, Kısacık, Bünyamın, Sayarlıoğlu, Mehmet, Çınar, Muhammed, Kaşifoğlu, Timuçin, Sarı, İsmail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Research and Education Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459332/ https://www.ncbi.nlm.nih.gov/pubmed/30489254 http://dx.doi.org/10.5152/eurjrheum.2018.18115 |
Ejemplares similares
-
The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia
por: YAŞAR BİLGE, N. Şule, et al.
Publicado: (2019) -
Validity and reliability of medication adherence scale in FMF (adult version)
por: Fidanci, Berna Eren, et al.
Publicado: (2014) -
Behçet Disease With Vascular Involvement: Effects of Different Therapeutic Regimens on the Incidence of New Relapses
por: Alibaz-Oner, Fatma, et al.
Publicado: (2015) -
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
por: KALYONCU, Umut, et al.
Publicado: (2021) -
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
por: Alpay Kanıtez, Nilüfer, et al.
Publicado: (2022)